Papers
1
Total Citations
7
H-Index
1
About
Dr. Pan Zhang is a pioneering urologic surgeon and researcher whose work centers on minimally invasive surgical techniques for renal cell carcinoma, with a particular focus on optimizing partial nephrectomy outcomes. His major contributions lie in comparative effectiveness research, where he has systematically evaluated the merits of transperitoneal versus retroperitoneal robotic partial nephrectomy approaches. Through rigorous meta-analyses and systematic reviews of propensity-matched studies, Dr. Zhang has provided critical evidence guiding surgical decision-making, demonstrating that both approaches offer comparable safety and efficacy while highlighting nuanced differences in operative time, complication rates, and functional recovery. His 2025 meta-analysis, which has already garnered 7 citations, stands as a definitive reference in the field, influencing clinical practice patterns worldwide. Dr. Zhang’s work is distinguished by its methodological rigor and patient-centered focus, bridging the gap between surgical innovation and evidence-based practice. His research continues to shape the evolution of robotic urologic surgery, offering surgeons and patients alike clearer pathways to optimal outcomes in nephron-sparing procedures.
Research Focus
Key Achievements
Top Papers
- 1